Hint mode is switched on Switch off

Viveve Medical, ordinary share
VIVE, US92852W5013

Add a stock to WL
Choose all Reset all
Viveve Medical, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

  • Issuer
  • Full borrower / issuer name
    Viveve Medical, Inc.
  • Industry
    Medical Devices

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    14.06.2016
  • Lock up period
    180
  • Number of papers
    2,700,000
  • Volume of raised funds
    13.5 mln USD
  • Final placement price
    5 USD
  • Price change since placement date
    -100%
  • By capitalization
    51.01 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    17.03.2017
  • Lock up period
    180
  • Number of papers
    7,500,000
  • Volume of raised funds
    30 mln USD
  • Placement share
    41.21%
  • Final placement price
    4 USD
  • Price change since placement date
    -100%
  • By capitalization
    72.8 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    09.02.2018
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    30 mln USD
  • Placement share
    33.99%
  • Final placement price
    3 USD
  • Price change since placement date
    -100%
  • By capitalization
    88.26 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    10.12.2018
  • Lock up period
    180
  • Number of papers
    13,333,334
  • Volume of raised funds
    20 mln USD
  • Placement share
    29.72%
  • Final placement price
    1.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    67.29 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    25.11.2019
  • Lock up period
    180
  • Number of papers
    978,202
  • Volume of raised funds
    1.52 mln USD
  • Placement share
    39.96%
  • Final placement price
    1.55 USD
  • Price change since placement date
    -100%
  • By capitalization
    3.79 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIVE
  • Placement
    14.01.2021
  • Lock up period
    180
  • Number of papers
    4,607,940
  • Volume of raised funds
    15.67 mln USD
  • Placement share
    67.97%
  • Final placement price
    3.4 USD
  • Price change since placement date
    -100%
  • By capitalization
    23.05 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2022
I q eng
II q eng
III q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

14/01/2023 Viveve Medical: Of This Current Report On Form 8k (including Exhibit 99.1), The Company Is Unable To Present A Plan To Regain Compliance With The Bid Price Rule And The Equity Rule To The Panel At The Hearing. Accordingly, Nasdaq Will Delist The Company By Filing A Form 25 Notification Of Delisting With The Securities And Exchange Commission. Following The Effectiveness Of The Delisting, The Company Intends To File A Form 15 With The Securities And Exchange Commission To Suspend Its Reporting Obligations Under The Securities Exchange Act Of 1934, As Amended
15/12/2022 Viveve Medical: Of This Current Report On Form 8k, Including Exhibit 99.1 Attached Hereto, Is Being Furnished And Shall Not Be Deemed Filed For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Subject To The Requirements Of Amended Item 10 Of Regulation Sk, Nor Shall It Be Deemed Incorporated By Reference Into Any Filing Of The Company Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing. The Furnishing Of This Information Hereby Shall Not Be Deemed An Admission As To The Materiality Of Any Such Information
01/12/2022 Viveve Medical: Of This Current Report On Form 8k, Including Exhibit 99.1 Attached Hereto, Is Being Furnished And Shall Not Be Deemed Filed For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Subject To The Requirements Of Amended Item 10 Of Regulation Sk, Nor Shall It Be Deemed Incorporated By Reference Into Any Filing Of The Company Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing. The Furnishing Of This Information Hereby Shall Not Be Deemed An Admission As To The Materiality Of Any Such Information
29/11/2022 Viveve Medical: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
18/11/2022 Viveve Medical: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
All organization news

Holders

Industry Leaders

Registration is required to get access.